Human growth hormone fragments 1-43 and 44-191: In vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems

Endocrinology

Volumn 137, Issue 1, 1996, Pages 90-95

  Rowlinson, Scott W ^b   Waters, Michael J ^b   Lewis, Urban J ^b   Barnard, Ross ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE;

ANIMAL CELL; ARTICLE; BIOASSAY; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIVER MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING;

EID: 0030066984     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.1.8536647     Document Type: Article

References (28)

1. Lewis UJ, Sinha YN, Haro LS 1994 Variant forms of human growth hormone in serum. Acta Paediatr [Suppl] 399:29-31
2. Ferrara N, Clapp C, Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900
3. Singh RNP, Seavey BK, Lewis LJ, Lewis UJ 1983 Human growth hormone peptide 1-43: isolation from pituitary glands. J Protein Chem 2:425-436
4. Frigeri LG, Wolff GL, Robel G 1983 Impairment of glucose tolerance in yellow (Avy/A) (BALB/c X VY) F-1 hybrid mice by hyperglycemic peptides(s) from human pituitary glands. Endocrinology 113:2097-2105
5. Salem MAM, Wolff GL 1989 Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a obese yellow Avy/A, and C57BL/ J-ob/ob mice. Proc Soc Exp Biol Med 191:113-123
6. Lewis UJ, Lewis LJ, Salem MAM, Staten NR, Galosy SS, Krivi GG 1991 A recombinant-DNA-derived modification of human growth hormone (hGH 44-191) with enhanced diabetogenic activity. Mol Cell Endocrinol 78:45-54
7. Kostyo JL 1986 The multivalent nature of growth hormone. In: Raiti S, Tolman RH (eds) Human Growth Hormone. Plenum Press, New York, p 449
8. Sinha YN, Jacobsen BP 1994 Human growth hormone (hGH)-(44-191), a reportedly diabetogenic fragment of hGH, circulates in human blood: measurement by radioimmunoassay. J Clin Endocrinol Metab 78:1411-1418
9. Haro LS, Singh RNP, Lewis UJ, Krivi GG, Human growth hormone deletion mutant (hGH 44-191) binds to lactogenic receptors but not to somatogenic receptors. Program of the Annual Meeting of The Endocrine Society, Atlanta GA, 1990, p 251 (Abstract 906)
10. Cunningham BC, Henner DJ, Wells JA 1990 Engineering human prolactin to bind to the human growth hormone receptor. Science 247:1461-1465
11. Cunningham BC, Wells JA 1991 Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88: 3407-3411
12. Obukowicz MG, Staten NR, Krivi GG 1992 Enhanced heterogenous gene expression in novel rpoH mutants of Escherichia coli. Appl Environ Microbiol 58:1511-1523
13. Staten NR, Byatt JC, Krivi GG 1993 Ligand-specific dimerization of the extracellular domain of the bovine growth hormone receptor. J Biol Chem 268:18467-18473
14. Barnard R, Quirk P, Waters MJ 1989 Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies. J Endocrinol 123:327-332
15. Barnard R, Rowlinson SW, Waters MJ 1990 Soluble forms of the rabbit adipose tissue and liver growth hormone receptors are antigenically identical, but the integral membrane forms differ. Biochem J 267:471-477
16. Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ 1981 Iodination of proteins, glycoproteins and peptides using a solid phase oxidizing agent, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycouril (iodogen). Anal Biochem 117:136-146
17. Rowlinson SW, Barnard R, Bastiras S, Robins AJ, Brinkworth R, Waters MJ 1994 A growth hormone agonist produced by targeted mutagenesis at binding site 1. J Biol Chem 270:16833-16839
18. Smith WC, Kuniyoshi J, Talamantes F 1989 Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains. Mol Endocrinol 3:984-990
19. Leung DW, Spencer SA, Cachaines G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
20. Scatchard G 1949 The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672
21. Gertler A, Shamay A, Cohen N, Ashkenazi A, Friesen HG, Levanon A, Gorecki M, Aviv H, Hadary D, Vogel T 1986 Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Endocrinology 118:720-726
22. Cunningham BC, Ultsch M, Abraham M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
23. Rowlinson SW, Barnard R, Bastiras S, Robins AJ, Senn C, Wells JRE, Brinkworth R, Waters MJ 1994 Evidence for involvement of the carboxy terminus of helix 1 of GH in receptor binding: use of charge reversal mutagenesis to account for calcium dependence of binding and for design of higher affinity analogues. Biochemistry 33:11724-11733
24. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680
25. De Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
26. Binder L, Vogel T, Hadary D, Elberg G, Gertler A 1989 Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity. Mol Endocrinol 3:923-930
27. Salem MAM 1988 Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats. Endocrinology 123:1565-1576
28. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685